Lumosa Therapeutics Licenses Long Acting Injectable Analgesic to Skyline Vet Pharma, Inc. for Use in Companion Animals
You may also like...
TWi Biotechnology, Inc. Announces Last Patient Enrolled in Phase 2 Study of AC-201CR for Treatment of Hemophilic Arthropathy
Ping An Good Doctor and BDMS Announce Strategic Cooperation, Providing Overseas Healthcare Solutions to Chinese Users